Aytu BioPharma (AYTU) News Today $1.50 +0.05 (+3.45%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Aytu BioPharma Proposes Settlement in Shareholder LawsuitDecember 5, 2024 | finance.yahoo.comAytu BioPharma First Quarter 2025 Earnings: Beats ExpectationsNovember 16, 2024 | finance.yahoo.comAytu BioScience Announces Leadership Change and Financial GrowthNovember 15, 2024 | markets.businessinsider.comAytu BioPharma Reports Q1 Fiscal 2025 EarningsNovember 15, 2024 | markets.businessinsider.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2025 Earnings Call TranscriptNovember 15, 2024 | msn.comAytu BioPharma Names Ryan Selhorn as CFONovember 14, 2024 | marketwatch.comAytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comAytu BioPharma (NASDAQ:AYTU) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comAytu BioPharma inks deal with Lupin for ADHD drugs in CanadaOctober 3, 2024 | investing.comAytu BioPharma Full Year 2024 Earnings: EPS Misses ExpectationsSeptember 28, 2024 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2024 Earnings Call TranscriptSeptember 28, 2024 | msn.comAytu BioPharma files mixed offeringSeptember 27, 2024 | msn.comAnalysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before LongSeptember 8, 2024 | finance.yahoo.comSidoti Events, LLC's Virtual August Micro-Cap ConferenceAugust 13, 2024 | finance.yahoo.comAytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 23, 2024 | finance.yahoo.comQ3 2024 Aytu Biopharma Inc Earnings CallMay 16, 2024 | finance.yahoo.comAytu BioPharma Inc (AYTU) Q3 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst ...May 16, 2024 | finance.yahoo.comAytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial ResultsMay 15, 2024 | finanznachrichten.deHere's what Wall Street expects from Aytu BioPharma's earnings reportMay 15, 2024 | markets.businessinsider.comAytu BioPharma Inc 0A8MApril 17, 2024 | morningstar.comRedHill Biopharma looks to raise $1.25M in a direct offering of securitiesApril 2, 2024 | msn.comAytu BioPharma Inc AYTUMarch 24, 2024 | morningstar.comSeelos drops as lead drug fails in ALS trialMarch 19, 2024 | seekingalpha.comSeelos Therapeutics files for 3.4M shares secondary offeringMarch 18, 2024 | seekingalpha.comAytu BioPharma (AYTU) Price Target Increased by 60.00% to 8.16February 25, 2024 | msn.comAytu BioPharma Second Quarter 2024 Earnings: Beats ExpectationsFebruary 16, 2024 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call TranscriptFebruary 16, 2024 | finance.yahoo.comQ2 2024 Aytu Biopharma Inc Earnings CallFebruary 15, 2024 | finance.yahoo.comAytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second QuarterFebruary 14, 2024 | finance.yahoo.comEarnings Preview: Aytu BioPharmaFebruary 13, 2024 | benzinga.comAytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024February 7, 2024 | finance.yahoo.comAytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024January 23, 2024 | finance.yahoo.comWhen Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?January 16, 2024 | finance.yahoo.comAytu BioPharma Stock (NASDAQ:AYTU) Dividends: History, Yield and DatesDecember 18, 2023 | benzinga.comAytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023November 30, 2023 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comAytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsNovember 14, 2023 | finanznachrichten.deAytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsNovember 14, 2023 | finance.yahoo.comAytu BioPharma earnings: here's what to expectNovember 13, 2023 | markets.businessinsider.comAytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive YearNovember 8, 2023 | finance.yahoo.comAytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023November 7, 2023 | finance.yahoo.comAytu BioPharma, Inc.: Aytu BioPharma Announces Approval of the Cotempla XR-ODT Manufacturing Site Transfer Prior Approval SupplementOctober 28, 2023 | finanznachrichten.deAytu BioPharma: Strategic Manufacturing Transition and Financial Growth Bolster Buy RatingOctober 28, 2023 | markets.businessinsider.comAytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval SupplementOctober 26, 2023 | finance.yahoo.comAytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023October 9, 2023 | finance.yahoo.comThere's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted RevenuesSeptember 28, 2023 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call TranscriptSeptember 28, 2023 | finance.yahoo.comAytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023September 27, 2023 | finance.yahoo.comEarnings Outlook For Aytu BioPharmaSeptember 26, 2023 | benzinga.comAytu BioPharma earnings: here's what Wall Street expectsSeptember 26, 2023 | markets.businessinsider.com Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address liberals FOOLED by Elon’s shocking surprise (Ad)Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH… Click here to discover the real reason Elon Musk became buddy-buddy with Trump. AYTU Media Mentions By Week AYTU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AYTU News Sentiment▼1.890.59▲Average Medical News Sentiment AYTU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AYTU Articles This Week▼10▲AYTU Articles Average Week Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OKYO Pharma News Elevation Oncology News Outlook Therapeutics News Anebulo Pharmaceuticals News Lantern Pharma News Verrica Pharmaceuticals News BioAtla News RenovoRx News Marker Therapeutics News ProMIS Neurosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AYTU) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
